iShares Biotechnology ETF $IBB Shares Sold by Lido Advisors LLC

Lido Advisors LLC reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 62.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,350 shares of the financial services provider’s stock after selling 20,288 shares during the period. Lido Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,086,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Allspring Global Investments Holdings LLC lifted its stake in iShares Biotechnology ETF by 46,806.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock worth $7,927,000 after purchasing an additional 46,806 shares in the last quarter. Tudor Investment Corp ET AL purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $931,000. McElhenny Sheffield Capital Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $25,400,000. WorthPointe LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $1,424,000. Finally, Assetmark Inc. lifted its position in iShares Biotechnology ETF by 150,979.6% during the fourth quarter. Assetmark Inc. now owns 74,029 shares of the financial services provider’s stock worth $12,494,000 after buying an additional 73,980 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $188.14 on Monday. iShares Biotechnology ETF has a fifty-two week low of $130.25 and a fifty-two week high of $199.05. The stock’s fifty day moving average is $179.53 and its two-hundred day moving average is $174.10.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were paid a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.